Abstract: Disclosed herein are compounds and compositions useful in the treatment of GLS1 mediated diseases, such as cancer, having the structure of Formula I: Methods of inhibition GLS1 activity in a human or animal subject are also provided.

Abstract: A modular point-of-sale display comprising a plurality of inter-lockable display units comprising a primary display unit comprising a primary multi-panel structure comprising a plurality of primary product display apertures configured and arranged to receive a plurality of first products for display a hanger element for mounting the primary display unit to a support structure; and a primary mounting element; and an add-on display unit comprising: an add-on structure comprising a plurality of add-on product display apertures configured and arranged to receive a plurality of second products for display; an add-on mounting element configured to mate with the primary mounting element to hang the add-on display unit from the primary display unit.

Abstract: Compounds of formula (VII), which are useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase, are provided. Also provided are pharmaceutical compositions, kits comprising said compounds, and methods and uses pertaining to said compounds.

Abstract: Described herein is a modular point-of-sale display comprising a plurality of inter-lockable display units comprising a primary display unit comprising a primary multi-panel structure comprising a plurality of primary product display apertures configured and arranged to receive a plurality of first products for display a hanger element for mounting the primary display unit to a support structure; and a primary mounting element; and an add-on display unit comprising: an add-on structure comprising a plurality of add-on product display apertures configured and arranged to receive a plurality of second products for display; an add-on mounting element configured to mate with the primary mounting element to hang the add-on display unit from the primary display unit.

Abstract: Disclosed herein are compounds and compositions useful in the treatment of GLS1 mediated diseases, such as cancer, having the structure of Formula I: Methods of inhibition GLS1 activity in a human or animal subject are also provided.

Abstract: Disclosed herein are compounds and compositions useful in the treatment of GLS1 mediated diseases, such as cancer, having the structure of Formula I: Methods of inhibition GLS1 activity in a human or animal subject are also provided.

Abstract: The present invention relates to compounds and methods useful as inhibitors of KDM5 for the treatment or prevention of cancer.

Abstract: Disclosed herein are compounds and compositions useful in the treatment of GLS1 mediated diseases, such as cancer, having the structure of Formula I: Methods of inhibition GLS1 activity in a human or animal subject are also provided.

Abstract: Disclosed herein are compounds and compositions useful in the treatment of GLS1 mediated diseases, such as cancer, having the structure of Formula I: Methods of inhibition GLS1 activity in a human or animal subject are also provided.

Abstract: Disclosed herein are compounds and compositions useful in the treatment of GLS1 mediated diseases, such as cancer, having the structure of Formula I: Methods of inhibition GLS1 activity in a human or animal subject are also provided.

Abstract: A laboratory vessel assembly includes a vessel body with a closed end, an open end, an engaging portion disposed inbetween, and two edges disposed longitudinally on two opposite portions of an outer surface of the engaging portion of the vessel body along one or more fusion lines of the vessel body; a vessel cap with a closed end, an open end, a receiving portion disposed inbetween, and one or more grooves disposed on an inner surface of the receiving portion along one or more fusion lines of the vessel cap; wherein the receiving portion of the vessel cap is configured to engage with the engaging portion of the vessel body to create one or more aeration gaps between the vessel body and the vessel cap along the grooves of the vessel cap and/or the edges of the vessel body.